Sanofi ADR
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $14,157,000 | $11,380,000 | $11,118,000 | $22,883,000 |
Gross Profit | 10,072,000 | 4,531,000 | 7,679,000 | 13,820,000 |
EBITDA | 4,247,000 | 2,026,000 | 2,865,000 | 1,644,500 |
EBIT | 3,768,000 | 1,527,000 | 2,864,956 | -1,346,500 |
Net Income | 2,815,000 | 1,113,000 | 1,133,000 | 1,970,000 |
Net Change In Cash | 14,157,000 | 11,380,000 | 11,118,000 | 22,883,000 |
Free Cash Flow | -504,000 | 4,587,000 | ||
Cash | 6,795,000 | -8,710,000 | 8,710,000 | |
Basic Shares | 1,258,800 | 1,258,800 | 2,497,600 | 2,507,200 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $46,033,000 | $45,389,000 | $39,175,000 | $37,369,000 |
Gross Profit | 31,817,000 | 31,694,000 | 26,920,000 | 25,210,000 |
EBITDA | 12,604,000 | 14,303,000 | 11,538,000 | 17,883,000 |
EBIT | 7,812,000 | 10,604,000 | 8,407,000 | 14,611,000 |
Net Income | 5,400,000 | 8,371,000 | 6,223,000 | 12,294,000 |
Net Change In Cash | 46,033,000 | 45,389,000 | 39,175,000 | 37,369,000 |
Free Cash Flow | 7,005,000 | 8,325,000 | 8,479,000 | 5,335,000 |
Cash | 8,710,000 | 12,736,000 | 10,098,000 | 13,915,000 |
Basic Shares | 1,256,400 | 2,513,800 | 2,515,800 | 2,520,200 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $1.57 |
2024-06-30 | $0.93 |
2024-03-31 | $0.97 |
2023-12-31 | $0.89 |
